Dana Hammell

Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) 48:15
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) Dana Hammell 4 54 года назад
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) 22:41
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) Dana Hammell 2 54 года назад
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) 25:57
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) Dana Hammell 6 54 года назад
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) 16:15
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) Dana Hammell 3 54 года назад
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age 17:44
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age Dana Hammell 2 54 года назад
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) 02:33:59
Drug Permeability: Best Practices for BCS-based Biowaivers (December 6, 2021) Dana Hammell 5 54 года назад
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age 02:32:48
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age Dana Hammell 7 54 года назад
Intro and Session 1 May11 2023 MCERSI workshop 02:07:43
Intro and Session 1 May11 2023 MCERSI workshop Dana Hammell 221 1 год назад
Session 1 Introduction-Dr. Joga Gobburu 00:39
Session 1 Introduction-Dr. Joga Gobburu Dana Hammell 88 1 год назад
Evaluating Immunosuppressive Effects of In Utero Exposure to Drug & Biologic Products July 12, 2024 03:42:26
Evaluating Immunosuppressive Effects of In Utero Exposure to Drug & Biologic Products July 12, 2024 Dana Hammell 56 4 месяца назад
Dr. Hao Zhu 21:07
Dr. Hao Zhu Dana Hammell 400 1 год назад
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age 02:49:59
Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age Dana Hammell 42 54 года назад
ADEPT 9:Enhancing Diversity in Therapeutics Development for Pediatric Patients (Session 2) 04:25:41
ADEPT 9:Enhancing Diversity in Therapeutics Development for Pediatric Patients (Session 2) Dana Hammell 60 3 месяца назад
August 31, 2023 FDA/M-CERSI PBBM Best Scientific Practices to Drive Drug Product Quality 03:36:32
August 31, 2023 FDA/M-CERSI PBBM Best Scientific Practices to Drive Drug Product Quality Dana Hammell 124 1 год назад
Dr. Tala Fakhouri 15:00
Dr. Tala Fakhouri Dana Hammell 305 1 год назад
Session 2 May 11 2023 MCERSI workshop 01:54:28
Session 2 May 11 2023 MCERSI workshop Dana Hammell 154 1 год назад
Session 1 Panel Discussion 32:03
Session 1 Panel Discussion Dana Hammell 226 1 год назад
Dr. James Lu 15:37
Dr. James Lu Dana Hammell 497 1 год назад
Dr. Mike Pacanowski 15:16
Dr. Mike Pacanowski Dana Hammell 179 1 год назад
Dr. Luca Foschini 19:57
Dr. Luca Foschini Dana Hammell 192 1 год назад

Сейчас ищут